Francis MeillandT won the hearts of judges to become the 2013 All-America Rose Selection.
Photos courtesy of All-America Rose Selections
Roses grown in the AARS test gardens are evaluated on a number of criteria, including:
- Form of buds and open blooms
- Color throughout the blooming cycle
- Aging quality
- Flowering effect
- Stem/cluster form
- Plant habit
- Disease resistance
- Repeat bloom quality
Make it an even 10: Rosa ‘Meitroni’, known in the trade as Francis Meilland™ (PP 19970), has become the tenth rose in All-America Rose Selections’ annual competition to stand alone. In more than 70 years of rigorous evaluations, only nine before Frances Meilland™ have been solo winners. (Last year’s winner, Sunshine Daydream, was the most recent soloist.)
Named this month to be the 2013 All-America Rose Selection, this Meilland International-bred beauty is a breathtaking hybrid tea introduced by Star Roses®/The Conard-Pyle Co. The large, pointed bud debuts white, delicately suffused with pearl pink. Upon opening, each large bloom is shell pink, which turns white as the flower ages. Sporting up to 60 to 65 petals and reaching a 4-inch diameter, this proud hybrid tea stands high-centered and cuplike on strong, upright stems. Plants reach 6 to 6½ feet tall and 3 feet wide.
Framed by very dark green, semi-glossy foliage, Francis Meilland™ blooms continuously throughout the season and exudes a robust fragrance described as fruity and citrusy. Disease tolerance is excellent for the type.
Francis Meilland™ is available through Conard-Pyle.
About the trials
Each AARS winning rose must excel in an extensive, two-year trial program where it’s judged on everything from rose disease resistance to flower production, color and fragrance. There are 15 test gardens located throughout the U.S., providing exposure to all climate zones and weather conditions. Average care-such as that given in a typical home garden-is provided, so that each rose’s performance can reflect “real world” conditions. In fact, AARS members recently elected to discontinue fungicidal sprays in order to more accurately replicate “normal” care.
For more information about the program, visit www.rose.org.